BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1233 related articles for article (PubMed ID: 18558448)

  • 21. [Postoperative three-dimensional conformal radiotherapy for resected non-small cell lung cancer].
    Ji W; Wang LH; Ou GF; Liang J; Feng QF; Xiao ZF; Chen DF; Lü JM; Zhou ZM; Zhang HX; Yin WB
    Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):783-6. PubMed ID: 19173815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of different chemotherapy regimens for concurrent chemoradiotherapy on locally advanced non-small cell lung cancer].
    Ren H; Wang LH; Wang XZ; Lü JM; Ji W; Zhou ZM; Ou GF; Yin WB
    Zhonghua Zhong Liu Za Zhi; 2009 Feb; 31(2):143-7. PubMed ID: 19538894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Outcome of three-dimensional conformal radiotherapy for early stage non-small cell lung cancer patients who met or not inclusion criteria for stereotactic-body radiation therapy].
    Kołodziejczyk M; Kępka L; Tyc-Szczepaniak D; Wierzchowski M
    Pneumonol Alergol Pol; 2011; 79(5):326-36. PubMed ID: 21861256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-dose conformal radiotherapy for patients with stage III non-small-cell lung carcinoma.
    Nakayama H; Satoh H; Kurishima K; Ishikawa H; Tokuuye K
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):645-50. PubMed ID: 20869582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High radiation dose may reduce the negative effect of large gross tumor volume in patients with medically inoperable early-stage non-small cell lung cancer.
    Zhao L; West BT; Hayman JA; Lyons S; Cease K; Kong FM
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):103-10. PubMed ID: 17363189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose-individualized stereotactic body radiotherapy for T1-3N0 non-small cell lung cancer: long-term results and efficacy of adjuvant chemotherapy.
    Chen Y; Guo W; Lu Y; Zou B
    Radiother Oncol; 2008 Sep; 88(3):351-8. PubMed ID: 18722684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involved-field radiation therapy for inoperable non small-cell lung cancer.
    Rosenzweig KE; Sura S; Jackson A; Yorke E
    J Clin Oncol; 2007 Dec; 25(35):5557-61. PubMed ID: 17984185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of acute esophagitis in lung cancer patients treated with concurrent three-dimensional conformal radiotherapy and chemotherapy.
    Rodríguez N; Algara M; Foro P; Lacruz M; Reig A; Membrive I; Lozano J; López JL; Quera J; Fernández-Velilla E; Sanz X
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):810-7. PubMed ID: 18755556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of acute esophagitis in patients with non-small-cell lung carcinoma treated with concurrent chemotherapy and hyperfractionated radiotherapy followed by surgery.
    Patel AB; Edelman MJ; Kwok Y; Krasna MJ; Suntharalingam M
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1106-12. PubMed ID: 15519781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of 3-dimensional conformal hypofractionated high-dose radiotherapy combined with chemotherapy for non-small-cell lung cancer: a clinical observation].
    Jiang HY; Wu DH; Chen LH
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Nov; 24(11):1297-8. PubMed ID: 15567785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
    Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
    Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dosimetric and clinical results of three-dimensional conformal radiotherapy for locally recurrent nasopharyngeal carcinoma.
    Zheng XK; Ma J; Chen LH; Xia YF; Shi YS
    Radiother Oncol; 2005 May; 75(2):197-203. PubMed ID: 15876464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved local control with higher doses of radiation in large-volume stage III non-small-cell lung cancer.
    Rengan R; Rosenzweig KE; Venkatraman E; Koutcher LA; Fox JL; Nayak R; Amols H; Yorke E; Jackson A; Ling CC; Leibel SA
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):741-7. PubMed ID: 15465190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The addition of induction chemotherapy with etoposide, ifosfamide, and cisplatin failed to improve therapeutic outcome of concurrent chemoradiotherapy in patients with locally advanced non-small cell lung cancer -- single institution retrospective analysis.
    Lee HW; Choi JH; Lim HY; Park JS; Kim HC; Kang S; Oh YT; Chun M; Sheen SS; Oh YJ; Park KJ; Hwang SC
    Neoplasma; 2006; 53(1):30-6. PubMed ID: 16416010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The incidence of perioperative anastomotic complications after sleeve lobectomy is not increased after neoadjuvant chemoradiotherapy.
    Milman S; Kim AW; Warren WH; Liptay MJ; Miller C; Basu S; Faber LP
    Ann Thorac Surg; 2009 Sep; 88(3):945-50; discussion 950-1. PubMed ID: 19699925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Radiation therapy for lung cancer].
    Shibuya K; Hiraoka M
    Gan To Kagaku Ryoho; 2007 Apr; 34(4):544-9. PubMed ID: 17431339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of overall treatment time on outcomes after concurrent chemoradiation for locally advanced non-small-cell lung carcinoma: analysis of the Radiation Therapy Oncology Group (RTOG) experience.
    Machtay M; Hsu C; Komaki R; Sause WT; Swann RS; Langer CJ; Byhardt RW; Curran WJ
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):667-71. PubMed ID: 15927409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Three-dimensional conformal radiotherapy for locally advanced (Stage II and worse) head-and-neck cancer: dosimetric and clinical evaluation.
    Portaluri M; Fucilli FI; Castagna R; Bambace S; Pili G; Tramacere F; Russo D; Francavilla MC
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1036-43. PubMed ID: 16750321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of radiation pneumonitis: dose-volume histogram analysis in 62 patients with non-small cell lung cancer after three-dimensional conformal radiotherapy.
    Piotrowski T; Matecka-Nowak M; Milecki P
    Neoplasma; 2005; 52(1):56-62. PubMed ID: 15739028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of outcomes for patients with medically inoperable Stage I non-small-cell lung cancer treated with two-dimensional vs. three-dimensional radiotherapy.
    Fang LC; Komaki R; Allen P; Guerrero T; Mohan R; Cox JD
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):108-16. PubMed ID: 16904517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 62.